Vagus nerve stimulation for epilepsy

Drug and Therapeutics Bulletin

Volumn 48, Issue 4, 2010, Pages 42-45

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

ANTICONVULSANT THERAPY; ASYSTOLE; CLINICAL EFFECTIVENESS; COUGHING; DYSPNEA; ELECTROSTIMULATION; EPILEPSY; EUROPE; FACIAL NERVE PARALYSIS; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HEALTH CARE COST; HOSPITAL COST; HUMAN; INFECTION; LARYNX DISORDER; MAJOR DEPRESSION; PAIN; PARESTHESIA; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; THERAPY EFFECT; TREATMENT INDICATION; VAGUS NERVE STIMULATION; VOICE CHANGE; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; PATIENT SELECTION; SEIZURE; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; SEIZURES; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 77952786289     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2010.02.0015     Document Type: Review

References (51)

1. Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2001; 10: 306-14; quiz 315-6.
2. Moran NF et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 2004; 13: 425-33. (Pubitemid 39022849)
3. Ben-Menachem E et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 616-26. (Pubitemid 24217765)
4. Ramsay RE et al. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 627-36. (Pubitemid 24217766)
5. Murphy JV et al. Left vagal nerve stimulation in children with refractory epilepsy. Preliminary observations. Arch Neurol 1995; 52: 886-9.
6. Parker AP et al. Vagal nerve stimulation in epileptic encephalopathies. Pediatrics 1999; 103: 778-82. (Pubitemid 29274471)
7. Kabir SM et al. Vagus nerve stimulation in children with intractable epilepsy: indications, complications and outcome. Childs Nerv Syst 2009; 25: 1097-100.
8. Cyberonics, 2010. Welcome to VNS therapy.com for healthcare professionals [online]. Available: http://www.vnstherapy.com/epilepsy/hcp/default.aspx [Accessed 30 March 2010].
9. Hatton KW et al. Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg 2006; 103: 1241-9. (Pubitemid 44627352)
10. Heck C et al. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 2002; 59: S31-7.
11. Vonck K et al. The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status. J Clin Neurophysiol 2001; 18: 394-401. (Pubitemid 33111563)
12. Vonck K et al. Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study. Seizure 2008; 17: 699-706.
13. Groves DA et al. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett 2005; 379: 174-9. (Pubitemid 40544529)
14. Henry TR et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 1999; 52: 1166-73. (Pubitemid 29177916)
15. Van Laere K et al. Perfusion SPECT changes after acute and chronic vagus nerve stimulation in relation to prestimulus condition and long-term clinical efficacy. J Nucl Med 2002; 43: 733-44. (Pubitemid 34663292)
16. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002; 1: 477-82. (Pubitemid 37159138)
17. Helmers SL et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol 2001; 16: 843-8. (Pubitemid 33150421)
18. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia 1990; 31: S40-3.
19. Privitera M et al. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2002, Issue 4. Art. No.: CD002896. DOI: 10.1002/14651858. CD002896 [Last assessed as up-to-date: 19 July 2007].
20. Kuba R et al. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure 2009; 18: 269-74.
21. Majoie HJ et al. Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness. J Clin Neurophysiol 2001; 18: 419-28. (Pubitemid 33111567)
22. Rossignol E et al. Vagus nerve stimulation in pediatric epileptic syndromes. Seizure 2009; 18: 34-7.
23. Parain D et al. Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 2001; 25: 213-6. (Pubitemid 32913137)
24. Murphy JV et al. Left vagal nerve stimulation in six patients with hypothalamic hamartomas. Pediatr Neurol 2000; 23: 167-8.
25. Chawla J et al. Intractable epilepsy with ring chromosome 20 syndrome treated with vagal nerve stimulation: case report and review of the literature. J Child Neurol 2002; 17: 778-80. (Pubitemid 36163694)
26. Murphy JV et al. Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center. Arch Pediatr Adolesc Med 2003; 157: 560-4. (Pubitemid 36693547)
27. Morris GL 3rd, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999; 53: 1731-5; erratum Neurology 2000; 54: 1712.
28. Benifla M et al. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv Syst 2006; 22: 1018-26. (Pubitemid 44103029)
29. Malow BA et al. Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients. Neurology 2001; 57: 879-84. (Pubitemid 32845511)
30. Chavel SM et al. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav 2003; 4: 302-9. (Pubitemid 37184606)
31. McLachlan RS et al. Quality of life after vagus nerve stimulation for intractable epilepsy: is seizure control the only contributing factor? Eur Neurol 2003; 50: 16-9. (Pubitemid 36736964)
32. Buoni S et al. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev 2004; 26: 158-63. (Pubitemid 38367898)
33. Mikati MA et al. Quality of life after vagal nerve stimulator insertion. Epileptic Disord 2009; 11: 67-74.
34. Park YD. The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilepsy Behav 2003; 4: 286-90. (Pubitemid 37184604)
35. Aldenkamp AP et al. Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with Lennox-Gastaut syndrome in an open clinical and nonrandomized study. Epilepsy Behav 2001; 2: 343-50. (Pubitemid 33653392)
36. McGlone J et al. Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can J Neurol Sci 2008; 35: 287-96.
37. Sherman EM et al. Quality of life and seizure outcome after vagus nerve stimulation in children with intractable epilepsy. J Child Neurol 2008; 23: 991-8.
38. Nakken KO et al. Vagal nerve stimulation - the Norwegian experience. Seizure 2003; 12: 37-41. (Pubitemid 36113761)
39. Rychlicki F et al. Complications of vagal nerve stimulation for epilepsy in children. Neurosurg Rev 2006; 29: 103-7.
40. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18: 415-8. (Pubitemid 33111566)
41. Annegers JF et al. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death. Epilepsia 1998; 39: 206-12. (Pubitemid 28074358)
42. Annegers JF et al. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death. Epilepsia 2000; 41: 549-53. (Pubitemid 30253427)
43. Nagarajan L et al. Respiratory pattern changes in sleep in children on vagal nerve stimulation for refractory epilepsy. Can J Neurol Sci 2003; 30: 224-7. (Pubitemid 37064517)
44. Hsieh T et al. Sleep-related breathing disorder in children with vagal nerve stimulators. Pediatr Neurol 2008; 38: 99-103.
45. Ben-Menachem E et al. Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients. Neurology 2002; 59: S44-7.
46. Forbes RB et al. Cost-utility analysis of vagus nerve stimulators for adults with medically refractory epilepsy. Seizure 2003; 12: 249-56. (Pubitemid 36806070)
47. Forbes R. Cost-utility of vagus nerve stimulation (VNS) therapy for medically refractory epilepsy - an update. Seizure 2008; 17: 387-88. (Pubitemid 351615301)
48. Department of Health, 2010. 2010-11 national tariff information: service, procedure, TFC, drug and device exclusions [online]. Available: http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/@ps/ documents/digitalasset/dh-113900.xls#'15.Serv,Proc,TFC,Drug&DevExcl.'!A1 [Accessed 30 March 2010].
49. Elger CE, Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008; 12: 501-39.
50. National Institute for Health and Clinical Excellence, 2004. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical guideline 20 [online]. Available: http://www.nice.org.uk/nicemedia/pdf/CG020fullguideline.pdf. [Accessed 30 March 2010].
51. National Institute for Health and Clinical Excellence, 2004. Vagus nerve stimulation for refractory epilepsy in children. [online]. Available: http://www.nice.org.uk/nicemedia/pdf/IPG050guidance.pdf. [Accessed 30 March 2010].